FBLG
FibroBiologics, Inc.
0.2408
-0.0222-8.44%
Dec 16, 4:00:01 PM EST

Upcoming Earnings 

Report date
≈ -/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
18.08M
P/E (TTM)
-
Basic EPS (TTM)
-0.48
Dividend Yield
0%

Recent Filings

About 

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.

CEO
Mr. Peter O'Heeron
IPO
1/31/2024
Website
https://www.fibrobiologics.com
Employees
13
Sector
Healthcare
Industry
Biotechnology

Related Companies  

AIBT
Aibotics Inc.
0.00+0.00
CERO
CERo Therapeutics Holdings, Inc
0.09-0.01
CMMB
Chemomab Therapeutics Ltd.
2.06+0.00
ETNB
89bio, Inc.
14.84+0.00
FBRX
Forte Biosciences, Inc.
23.27+1.31
FGEN
FibroGen, Inc
9.51-0.53
IMA
ImageneBio, Inc.
6.25+0.08
LGVN
Longeveron Inc.
0.55+0.00
RMTG
Regenerative Medical Technology
0.04+0.00
YDES
YD Bio Limited
12.62+0.22